ProfileGDS5678 / 1453339_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 42% 41% 41% 39% 40% 40% 39% 40% 40% 39% 40% 41% 40% 40% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.0045742
GSM967853U87-EV human glioblastoma xenograft - Control 22.9347941
GSM967854U87-EV human glioblastoma xenograft - Control 32.9363841
GSM967855U87-EV human glioblastoma xenograft - Control 42.845939
GSM967856U87-EV human glioblastoma xenograft - Control 52.8728940
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.9957540
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.9629839
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.9125740
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.9069640
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.8770439
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.9175940
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.9099741
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.9278140
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.9260540